Bank Julius Baer & Co
IDXX icon

Bank Julius Baer & Co’s Idexx Laboratories IDXX Stock Holding History

Bank Julius Baer & Co’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.9M Buy
122,801
+1,286
+1% +$721K 0.17% 111
2026
Q1 		$68.1M Sell
121,515
-110,293
-48% -$70.7M 0.21% 97
2025
Q4 		$157M Buy
231,808
+1,369
+0.6% +$932K 0.43% 61
2025
Q3 		$147M Sell
230,439
-2,824
-1% -$1.71M 0.42% 65
2025
Q2 		$125M Sell
233,263
-3,648
-2% -$1.74M 0.37% 74
2025
Q1 		$99.2M Buy
236,911
+13,070
+6% +$5.68M 0.32% 80
2024
Q4 		$99.1M Buy
223,841
+15,565
+7% +$6.83M 0.31% 78
2024
Q3 		$119M Buy
208,276
+4,348
+2% +$2.11M 0.4% 63
2024
Q2 		$108M Sell
203,928
-14,908
-7% -$7.48M 0.41% 58
2024
Q1 		$118M Buy
218,836
+7,135
+3% +$3.9M 0.45% 61
2023
Q4 		$118M Buy
211,701
+43,844
+26% +$20.6M 0.5% 58
2023
Q3 		$73.4M Buy
167,857
+11,575
+7% +$5.77M 0.43% 60
2023
Q2 		$78.5M Sell
156,282
-2,787
-2% -$1.34M 0.47% 55
2023
Q1 		$79.5M Sell
159,069
-2,712
-2% -$1.3M 0.51% 54
2022
Q4 		$66M Buy
161,781
+451
+0.3% +$175K 0.45% 59
2022
Q3 		$52.6M Sell
161,330
-2,932
-2% -$1.08M 0.4% 63
2022
Q2 		$57.6M Buy
164,262
+4,242
+3% +$1.73M 0.41% 61
2022
Q1 		$87.5M Buy
160,020
+3,021
+2% +$1.59M 0.52% 49
2021
Q4 		$103M Buy
156,999
+20,315
+15% +$12.8M 0.55% 45
2021
Q3 		$85M Buy
136,684
+13,710
+11% +$9.21M 0.53% 48
2021
Q2 		$77.7M Buy
122,974
+5,099
+4% +$2.82M 0.49% 49
2021
Q1 		$57.7M Sell
117,875
-43,541
-27% -$21.8M 0.43% 55
2020
Q4 		$80.7M Buy
161,416
+154,591
+2,265% +$69.2M 0.66% 41
2020
Q3 		$2.68M Buy
6,825
+1,225
+22% +$453K 0.03% 194
2020
Q2 		$1.85M Sell
5,600
-2,396
-30% -$694K 0.02% 201
2020
Q1 		$1.94M Buy
+7,996
New +$2.09M 0.04% 156

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bank Julius Baer & Co's IDXX Position: Q2 2026 in Review

Bank Julius Baer & Co increased its Idexx Laboratories (IDXX) stake by 1.1% in Q2 2026, buying an estimated $721K and bringing the position to 122,801 shares worth $64.9M. The position accounts for 0.17% of the portfolio, ranked #111.

Bank Julius Baer & Co first reported a position in IDXX in Q1 2020 and has held it in 26 quarters since. The position peaked at $157M in Q4 2025. 1,301 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Bank Julius Baer & Co held 122,801 shares of Idexx Laboratories worth $64.9M as of Q2 2026.
  • Bank Julius Baer & Co bought 1,286 Idexx Laboratories shares in Q2 2026, an estimated $721K.
  • Idexx Laboratories made up 0.17% of Bank Julius Baer & Co's portfolio in Q2 2026, its #111 holding.
  • Bank Julius Baer & Co first reported a position in Idexx Laboratories in Q1 2020 and has held it in 26 quarters since.
  • Bank Julius Baer & Co's Idexx Laboratories position peaked at $157M in Q4 2025.
  • 1,301 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.